Marco Londei
2019
In 2019, Marco Londei earned a total compensation of $3.1M as Former Chief Medical Officer at ANAPTYSBIO, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $108,720 |
|---|---|
| Option Awards | $2,527,242 |
| Salary | $453,000 |
| Other | $9,564 |
| Total | $3,098,526 |
Londei received $2.5M in option awards, accounting for 82% of the total pay in 2019.
Londei also received $108.7K in non-equity incentive plan, $453K in salary and $9.6K in other compensation.
Rankings
In 2019, Marco Londei's compensation ranked 3,960th out of 13,971 executives tracked by ExecPay. In other words, Londei earned more than 71.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,960 out of 13,971 | 72nd |
Division Manufacturing | 1,429 out of 5,701 | 75th |
Major group Chemicals And Allied Products | 503 out of 2,200 | 77th |
Industry group Drugs | 425 out of 1,886 | 78th |
Industry Pharmaceutical Preparations | 323 out of 1,398 | 77th |
Source: SEC filing on April 27, 2020.
Londei's colleagues
We found three more compensation records of executives who worked with Marco Londei at ANAPTYSBIO in 2019.